Industry partnerships are vital in driving the development of innovative treatments for patient benefit.
The ECMC acts as a single point of entry to a UK wide network of scientific and clinical experts to help deliver early-phase innovative trials, driving the development of cancer treatments of tomorrow. We have access to adult and paediatric patient populations though our integration with the NHS.
By 2022, Cancer Research UK, the National Institute of Health Research in England and the Health Departments for Scotland, Wales and Northern Ireland will have invested over £100m in the ECMC network's research infrastructure to support the delivery of your trials.
The ECMC is extremely good, very helpful, initial kick off introductions have gone well, very impressive and responsive
Oncology R&D leader
The Experimental Cancer Medicine Centre initiative is jointly funded by Cancer Research UK, the National Institute for Health Research in England and the Departments of Health for Scotland, Wales and Northern Ireland.